Intas Pharmaceuticals Limited Enalapril Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Enalapril Export Records India — #11 Exporter, 442 Shipments, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Enalapril

India Pharmaceutical Trade Intelligence

$235.3M261 Suppliers115 CountriesHS 30049071

ExportsIndia → HUNGARY83.4%India → SOUTH AFRICA4.2%

ImportsMALTA → India$658.8K UNITED STATES → India$80.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Intas Pharmaceuticals Limited — Enalapril Exporter #11 | $1.1M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Enalapril Exporter Profile

Indian Pharmaceutical Exporter · #11 for Enalapril · $1.1M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #11 Indian exporter of Enalapril with $1.1M in export value and 442 verified shipments. Intas Pharmaceuticals Limited holds a 0.7% market share in Enalapril exports across 12 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Enalapril Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Enalapril export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Enalapril?

Country	Value	Shipments	Share
NETHERLANDS	$806.5K	192	70.4%
UNITED KINGDOM	$183.9K	49	16.0%
TRINIDAD & TOBAGO	$57.5K	5	5.0%
TRINIDAD AND TOBAGO	$26.1K	2	2.3%
KENYA	$22.0K

Who Are the Top Buyers of Enalapril from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	NETHERLANDS	$260.8K	54
BROCACEF NL : HUB	NETHERLANDS	$238.6K	71
ACCORD UK	UNITED KINGDOM	$127.2K	34
BROCACEF NL HUB	NETHERLANDS	$113.0K	17
BROCACEF NL:EU HUB	NETHERLANDS	$95.3K	10
BROCACEF NL : LOCAL	NETHERLANDS	$69.1K	26
BRYDEN PI LIMITED.	TRINIDAD & TOBAGO	$44.2K	2
BRYDEN PI LIMITED	TRINIDAD & TOBAGO	$39.5K	5
BROCACEF NL : DUTCH	NETHERLANDS	$39.2K	12
BROCACEF NL:DUTCH	NETHERLANDS	$37.3K	7

Intas Pharmaceuticals Limited supplies Enalapril to 28 buyers globally. The largest buyer is TO THE ORDER (NETHERLANDS), followed by BROCACEF NL : HUB (NETHERLANDS) and ACCORD UK (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Enalapril Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI ENALAPRIL 5MG 10X10T	$69.6K	7
PHARMA DRUGS & MEDI ENALAPRIL 20MG 10X10	$68.7K	9
PHARMA DRUGS & MEDI ENALAPRIL 10MG 10X10	$68.6K	10
PHARM DRUG&MED:ENALAPRIL 20MG 10X10T (ACCORD-DKSE)EACH UNCOATED TABLET CONTAINSENALAPRIL MALEATE PH.EUR. .....20 MG	$45.5K	4
PHARMA DRUG&MED:Enapril 10(Enalapril 10m	$44.2K	2
PHARMA DRUGS & MEDI ENALAPRIL 10MG 9X10T (ACCORD-NL AS PER INVOICE	$41.8K	13
PHARMACEUTICAL DRUGS AND MEDICINE ENALAPRIL 10MG 9X10T ACCORD NL AS PER INVOICE	$38.8K	5
PHARMA DRUGS & MEDI ENALAPRIL 5MG 10X10T (ACCORD-DKSE AS PER INVOICE	$38.1K	15
PHARMA DRUGS & MEDI ENALAPRIL MALEATE 20MG 2X14TACCORD-UK AS PER DOCUMENT	$35.6K	5
PHARM DRUG&MED:ENALAPRIL 10MG 9X10T (ACCORD-NL)EACH UNCOATED TABLET CONTAINS ENALAPRIL MALEATE PH.EUR. .....10MG	$34.8K	2

Intas Pharmaceuticals Limited exports 169 distinct Enalapril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI ENALAPRIL 5MG 10X10T with 7 shipments worth $69.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Enalapril Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	EMIL PHARMACEUTICAL INDUSTRIES PVT LTD	$1.2M	46	2	$27.0K
10	CADILA PHARMACEUTICALS LIMITED	$1.1M	108	15	$10.5K
11	INTAS PHARMACEUTICALS LIMITED ★	$1.1M	442	12	$2.5K
13	MEDOPHARM	$1.0M	84	12	$12.4K
14	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$1.0M	71	3	$14.3K

Intas Pharmaceuticals Limited ranks #11 among 261 Indian Enalapril exporters. Average shipment value of $2.5K compared to the market average of $124.2K. The closest competitors by value are EMIL PHARMACEUTICAL INDUSTRIES PVT LTD and CADILA PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Enalapril Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	474	13.9%
DELHI AIR CARGO ACC (INDEL4)	340	10.0%
SAHAR AIR	254	7.5%
JNPT/ NHAVA SHEVA SEA	229	6.7%
SAHAR AIR CARGO ACC (INBOM4)	222	6.5%
JNPT	213	6.3%
DELHI AIR	210	6.2%
MUNDRA SEA (INMUN1)	124	3.6%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Enalapril Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Enalapril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 445 individual customs records matching Intas Pharmaceuticals Limited exporting Enalapril, covering 169 formulations to 14 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 583+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Enalapril

Enalapril

Intas Pharmaceuticals Limited — Enalapril Exporter Profile

Intas Pharmaceuticals Limited — Enalapril Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Enalapril?

Who Are the Top Buyers of Enalapril from Intas Pharmaceuticals Limited?

What Is India's Total Enalapril Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Enalapril Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Enalapril Exporters?

What Enalapril Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Enalapril to Key Markets

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Enalapril Exporters?

Which Indian Ports Ship Enalapril Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Enalapril Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Enalapril Export Data from Intas Pharmaceuticals Limited

Enalapril Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source